NHS gets 12 years to roll out new weight-loss drug
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Comedian Jim Gaffigan’s Weight Loss Transformation Over the Years After Shedding 50 Pounds
Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...
Eli Lilly stock higher following surprise weight loss treatment data
Analysts see the market for GLP-1 weight loss treatments rising to around $70 billion over the next five years.
AOL2h
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
It comes as a trial by Mounjaro manufacturer Eli Lilly – known as Surmount-5 – found patients on tirzepatide recorded a ...
NHS Mounjaro warning as 90 per cent of people will be disappointed
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout
Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...
Eli Lilly’s Zepbound outperforms Novo's Wegovy for weight loss in head-to-head trial
Eli Lilly's weight-loss drug Zepbound outperformed Novo Nordisk's Wegovy in a head-to-head trial, leading to a rise ...
Lilly's Head-To-Head Data Lands Blow On Novo In Battle For Weight Loss Supremacy
Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.
BioSpace12h
Lilly Claims Key Weight Loss Victory Over Novo in Head-to-Head Study
SURMOUNT-5’s results reflect those of multiple real-world studies, which have found that tirzepatide treatment results in ...
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to ...